Welcome to the February edition of the Baker McKenzie Ukraine Healthcare Industry Group Newsletter. This is your regular digest of legal developments affecting the life science and healthcare industries in Ukraine.
This edition covers the delayed implementation and expected recast of the reference pricing for pharmaceuticals, changes in the state regulation of pricing for medical devices, and the draft strategy on implementing the state pharmaceuticals policy for 2017-2025. More details on these developments in the Ukrainian life science and healthcare industries are described below.
In this issue:
- Reference pricing and reimbursement of pharmaceuticals
- Changes in the state regulation of prices for medical devices
- Draft strategy on implementing the state pharmaceuticals policy for 2017-2025